News
Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...
Pfizer has concluded a global licensing agreement with 3SBio, excluding China, which grants it exclusive rights for the 3SBio’s SSGJ-707.
New York City mayoral candidate Zohran Mamdani told business leaders that he would begin to discourage the use of the phrase ...
Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with nmHSPC, but only as a combination therapy.
My key takeaways from this conference included the importance of relational and developmental leadership, systems literacy and the democratization of leadership tools.
Pfizer vice president, interim provost give leadership advice at first ‘Lunch and Learn’ Beth McCormick and Megan Zwart provide insight into their career paths at first of event series ...
In a year in which he withstood a challenge from an activist investor, Pfizer CEO Albert Bourla received a 14% pay raise to $24.6 million in 2024.
Executives from TailorCare, Altera Digital Health, and WiPro shared insights at the ViVE 2025 conference in Nashville.
"We are thrilled by our collaboration with Pfizer to develop new data integration, analytics, and knowledge graph AI capabilities for accelerating drug discovery and development," said Janusz ...
/ February 4, 2025 / Data4Cure today announced an ongoing multi-year partnership with Pfizer, aimed at leveraging advanced analytics and knowledge graph AI to drive innovation in Pfizer’s drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results